Fingerprint
Dive into the research topics of 'Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
Matthew P. Goetz, David Toft, Joel Reid, Matthew Ames, Bridget Stensgard, Stephanie Safgren, Araba A. Adjei, Jeff Sloan, Pamela Atherton, Vlad Vasile, Sandra Salazaar, Alex Adjei, Gary Croghan, Charles Erlichman
Research output: Contribution to journal › Article › peer-review
304
Scopus
citations